FACTORS ASSOCIATED WITH THE INITIATION OF BIOLOGIC DISEASE MODIFYING ANTI RHEUMATIC DRUGS IN A PRIVATELY INSURED POPULATION WITH RHEUMATOID ARTHRITIS BETWEEN 2004 AND 2013 von Atzinger, CB, Guo, JJ, Kelton, CM

Volltext

Rifaximin, a Nonabsorbed Oral Antibiotic, Prevents Shigellosis after Experimental Challenge von Taylor, David N., McKenzie, Robin, Durbin, Anna, Carpenter, Colleen, Atzinger, Christophe B., Haake, Robert, Bourgeois, A. Louis

Volltext

CD200+ fibroblasts form a pro-resolving mesenchymal network in arthritis von Rauber, Simon, Mohammadian, Hashem, Schmidkonz, Christian, Atzinger, Armin, Soare, Alina, Treutlein, Christoph, Kemble, Samuel, Mahony, Christopher B., Geisthoff, Manuel, Angeli, Mario R., Raimondo, Maria G., Xu, Cong, Yang, Kai-Ting, Lu, Le, Labinsky, Hannah, Saad, Mina S. A., Gwellem, Charles A., Chang, Jiyang, Huang, Kaiyue, Kampylafka, Eleni, Knitza, Johannes, Bilyy, Rostyslav, Distler, Jörg H. W., Hanlon, Megan M., Fearon, Ursula, Veale, Douglas J., Roemer, Frank W., Bäuerle, Tobias, Maric, Hans M., Maschauer, Simone, Ekici, Arif B., Buckley, Christopher D., Croft, Adam P., Kuwert, Torsten, Prante, Olaf, Cañete, Juan D., Schett, Georg, Ramming, Andreas

Volltext